TipRanks
pc:artio

Artios Pharma Limited

The Glenn Berge Building Babraham Research Campus Cambridge, CB22 3FH, GB
https://www.artios.com/
A biopharmaceutical company committed to realizing the therapeutic power of targeting the DNA damage response (DDR) in cancer. Artios is pioneering next-generation approaches in the DDR field through its comprehensive anti-cancer approach and the deep experience of its team of DDR drug developers.

Leadership & Board

Current Number of Employees128
Current LinkedIn Followers13,701

Latest Estimated Valuation

Estimated Valuation―
Estimated Valuation―
Total Amount Raised$115M
Total Amount Raised$115M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$115M
Latest Funding Amount$115M
Latest Funding RoundSeries D
Latest Funding RoundSeries D
Post-Money Valuation―
Post-Money Valuation―

Employee Trend

Artios Pharma Limited had 128 employees as of October 5, 2026. The number of employees increased by 0 (0.00%) week-over-week.
128Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

Artios Pharma Limited had 13,701 followers as of October 5, 2026. The number of followers increased by 17 (0.12%) week-over-week.
13,701Latest Followers Count
17(0.12%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Main Enterprise Clients

A snapshot of major enterprise customers that use this private company’s products or services, highlighting its commercial reach and market adoption.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Nov 17, 2025
Series D
$115.00M
―

Investors

Investor Name
Funding Round

Similar Companies

A snapshot of private companies similar to Artios Pharma Limited, helping you discover and navigate related company profiles.

Related News and Analysis